SITE012-0096

SITE012 (BRA) › SITE012-0096

SITE012-0096

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2026-01-01

enrolled

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-02-25 (study day 237); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.